Company Filing History:
Years Active: 2022-2024
Title: Innovations of Jianjun Zhang in Pharmaceutical Preparations
Introduction
Jianjun Zhang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicine, particularly in the development of pharmaceutical preparations. With a total of 2 patents to his name, his work focuses on enhancing the efficacy and stability of anticoagulant medications.
Latest Patents
One of Jianjun Zhang's latest patents is titled "Instant release pharmaceutical preparation of anticoagulant and preparation method therefor." This invention pertains to an instant release pharmaceutical preparation that includes a vicagrel compound or a pharmaceutically acceptable form thereof. The preparation can be in the form of a tablet or a capsule, with the vicagrel provided at a suitable particle size, specifically with a D90 of less than 50 μm. The pharmaceutical preparation exhibits rapid release characteristics in in vitro dissolution tests and shows considerable advantages in pharmacokinetics in vivo, indicating a greater degree and rate of drug absorption. The patent also outlines a method for preparing this instant release pharmaceutical preparation, ensuring excellent stability through a combination of optional preparation steps.
Career Highlights
Jianjun Zhang is currently associated with Jiangsu Vcare Pharma Tech Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations and enhancing patient outcomes.
Collaborations
Jianjun has collaborated with notable colleagues, including Yanlei Zhao and Xuefang Liu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Jianjun Zhang's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a key inventor in the development of effective anticoagulant preparations. His work not only advances medical science but also improves therapeutic options for patients.